GRT Course Part 3: Sample Size and Power

Автор: NIH ODP

Загружено: 2025-03-20

Просмотров: 106

Описание: Part 3 explores power and sample size for GRTs, IRGT trials, and SWGRTs. It introduces resources from the NIH Research Methods Resources website that can be used for power and sample size estimation in these designs and provides a brief tutorial for sample size estimation in a parallel GRT.

Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...

GRT Course Part 3: Sample Size and Power

Доступные форматы для скачивания:

Скачать видео

Информация по загрузке:

Скачать аудио

Похожие видео

GRT Course Part 4: Alternative Designs

GRT Course Part 4: Alternative Designs

Group-Randomized Trials in Public Health and Medicine

Group-Randomized Trials in Public Health and Medicine

GRT Course-Part 7: Alternative Designs: Pragmatic and Group-Randomized Trials

GRT Course-Part 7: Alternative Designs: Pragmatic and Group-Randomized Trials

Implications of Informative Cluster Size for Design & Analysis of Cluster Randomized Trials (MTG)

Implications of Informative Cluster Size for Design & Analysis of Cluster Randomized Trials (MTG)

Computational Models: Health Effects of Menthol Cigarettes & Benefits of a Menthol Ban (MtG)

Computational Models: Health Effects of Menthol Cigarettes & Benefits of a Menthol Ban (MtG)

GRT Course Part 1: Randomized Designs for Clinical Trials

GRT Course Part 1: Randomized Designs for Clinical Trials

Emerging Evidence for Strategies to Prevent Alzheimer’s Disease (pFocus)

Emerging Evidence for Strategies to Prevent Alzheimer’s Disease (pFocus)

Insights into the Efficiency and Benefits of Staircase Cluster Randomized Trial Designs (MtG)

Insights into the Efficiency and Benefits of Staircase Cluster Randomized Trial Designs (MtG)

Global Food Security: Research to Inform Evidence-based Policies and Practices (pFocus)

Global Food Security: Research to Inform Evidence-based Policies and Practices (pFocus)

Type 1 Diabetes Management in the U.S.: Epidemiologic Evidence, Trends, & Emerging Challenges (ESIL)

Type 1 Diabetes Management in the U.S.: Epidemiologic Evidence, Trends, & Emerging Challenges (ESIL)